Related Experiment Video

Updated: Aug 14, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced G1 cell cycle arrest

M E Ewen1

  • 1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

The Journal of Laboratory and Clinical Medicine
|October 1, 1996
PubMed

Insights

Transforming growth factor-beta (TGF-β) triggers cell cycle arrest by reducing cyclin-dependent kinase 4 (cdk4) levels and inhibiting cyclin-dependent kinase 2 (cdk2) activity. This dual action, involving p53 and specific inhibitors, controls cell proliferation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cell cycle progression is regulated by cyclin-dependent kinases (CDKs) and their inhibitors.
  • Transforming growth factor-beta (TGF-β) is a key cytokine involved in cell growth, differentiation, and apoptosis.
  • Dysregulation of cell cycle control is a hallmark of cancer.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which TGF-β induces cell cycle arrest.
  • To identify the specific CDKs and regulatory proteins involved in TGF-β-mediated cell cycle control.
  • To understand the role of p53 and CDK inhibitors in TGF-β signaling.

Main Methods:

  • Analysis of cdk4 and cdk2 activity and expression levels in response to TGF-β.
  • Investigation of the role of p53 in TGF-β-induced cell cycle arrest.
  • Identification of CDK inhibitors, such as p15 and p27, mediating TGF-β effects.
  • Study of the 5' untranslated region (UTR) of cdk4 in translational regulation.

Main Results:

  • TGF-β down-regulates cdk4 levels via translational inhibition, dependent on p53 and the cdk4 5' UTR.
  • TGF-β inhibits cdk2 activity through the induction of the CDK inhibitor p27.
  • TGF-β also induces the expression of p15, a cdk4-specific inhibitor.
  • Mutant p53 confers resistance to TGF-β by abrogating cdk4 down-regulation and cdk2 inhibition.

Conclusions:

  • TGF-β employs a multi-pronged strategy to arrest the cell cycle, targeting both cdk4 and cdk2.
  • The p53 tumor suppressor plays a critical role in mediating TGF-β's effects on cdk4 expression.
  • CDK inhibitors p15 and p27 are key effectors of TGF-β-induced cell cycle arrest.
  • Understanding these pathways is crucial for developing targeted cancer therapies.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...